Line 9: | Line 9: | ||
</head> | </head> | ||
<body> | <body> | ||
− | + | <div class="content_wrapper"> | |
− | + | ||
<div class="scu_project_image_wrapper_wide" id="scu_nav_wrapper"> | <div class="scu_project_image_wrapper_wide" id="scu_nav_wrapper"> | ||
<div class="lee_article"> | <div class="lee_article"> | ||
Line 18: | Line 17: | ||
<p class="scu_title">Rhythmic Production of Melatonin in <i>E.coli</i></p> | <p class="scu_title">Rhythmic Production of Melatonin in <i>E.coli</i></p> | ||
</div> | </div> | ||
− | < | + | <div class="scu_vice_title">SCU_China</div> |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<div class="scu_down" id="scu_down"> | <div class="scu_down" id="scu_down"> | ||
<p class="scu_down">learn more about us</p> | <p class="scu_down">learn more about us</p> | ||
Line 134: | Line 121: | ||
</div> | </div> | ||
<div class="overview-sub-title">SCU_China</div> | <div class="overview-sub-title">SCU_China</div> | ||
+ | <p class="scu_main_page_content_p2"> | ||
+ | Nowadays, insomnia and circadian rhythm disorders are increasingly plaguing | ||
+ | individuals' daily life. The circadian rhythm in human is predominantly under the | ||
+ | regulation of melatonin, a hormone produced by pineal gland periodically in | ||
+ | accordance with day-and-night photoperiod. This year we want to use engineered | ||
+ | <i>E.coli</i> to mimic this process in human as a promising dosing machine. We propose to | ||
+ | <strong>construct the melatonin biosynthesis pathway in <i>E.coli</i> to produce melatonin</strong>, and | ||
+ | simultaneously <strong>couple this process with optimized repressilator</strong>, a synthetic genetic | ||
+ | oscillator with higher precision and stability, to magnify the function of | ||
+ | repressilator and <strong>render melatonin production resemble mammalian periodicity in | ||
+ | <i>E.coli</i></strong>. | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="scu_hp_image_single_main"> | ||
+ | <img src="https://static.igem.org/mediawiki/2017/7/7d/T-SCU_China-2017_Team_fig1.jpg"> | ||
</div> | </div> | ||
<div class="col-lg-4 col-md-6 col-xs-12 scu_main_page_content"> | <div class="col-lg-4 col-md-6 col-xs-12 scu_main_page_content"> | ||
Line 143: | Line 145: | ||
1. Our human practices were integrated to the whole process, which made us | 1. Our human practices were integrated to the whole process, which made us | ||
complete | complete | ||
− | the project better. | + | the project better.<br> |
2. We improved two previous part BBa_I13521 and BBa_E2050 and our BioBrick work | 2. We improved two previous part BBa_I13521 and BBa_E2050 and our BioBrick work | ||
well | well | ||
− | in lab condition. | + | in lab condition.<br> |
3. Our experimental design based on modelling results, such as the optimal | 3. Our experimental design based on modelling results, such as the optimal | ||
− | proportioning of synthetase. | + | proportioning of synthetase.<br> |
4. Engineered E.coli is cultured with artificial gastrointestinal juices and gut | 4. Engineered E.coli is cultured with artificial gastrointestinal juices and gut | ||
flora to validate the substantial integration and survival condition based on | flora to validate the substantial integration and survival condition based on | ||
Line 163: | Line 165: | ||
<p class="scu_main_page_content_p" id="middle"> | <p class="scu_main_page_content_p" id="middle"> | ||
1. There are 4 new BioBrick parts in our project as follow, BBa_K2276001, | 1. There are 4 new BioBrick parts in our project as follow, BBa_K2276001, | ||
− | BBa_K2276003, BBa_K2276004 and BBa_K2206005. | + | BBa_K2276003, BBa_K2276004 and BBa_K2206005.<br> |
2. We collaborated with SCU-WestChina and SiCAU-China in experiments and human | 2. We collaborated with SCU-WestChina and SiCAU-China in experiments and human | ||
practice, received key assists from Peking University and offered wiki design | practice, received key assists from Peking University and offered wiki design | ||
− | suggestions to team Purdue. | + | suggestions to team Purdue.<br> |
3. We consulted experts of China Food and Drug Administration and West China | 3. We consulted experts of China Food and Drug Administration and West China | ||
Sleeping Centre for both experimental designs and safety problems. Also, we | Sleeping Centre for both experimental designs and safety problems. Also, we | ||
Line 178: | Line 180: | ||
</div> | </div> | ||
<div class="scu_main_page_content_wrapper" id="right_wrapper"> | <div class="scu_main_page_content_wrapper" id="right_wrapper"> | ||
− | <p | + | <p class="scu_main_page_content_p" id="right"> |
− | 1. We constructed a team successfully, sharing not only academic knowledge but also | + | 1. We constructed a team successfully, sharing not only academic knowledge but |
− | life experiences with each other. | + | also |
+ | life experiences with each other.<br> | ||
2.We received many kindly help from surroundings, including our college, | 2.We received many kindly help from surroundings, including our college, | ||
− | instructor, experts in various fields, friendly fraternal teams and so on.We have clearly acknowledged their works. | + | instructor, experts in various fields, friendly fraternal teams and so on.We |
− | 3. We managed to meet all the Deliverables standards. | + | have clearly acknowledged their works.<br> |
+ | 3. We managed to meet all the Deliverables standards.<br> | ||
4. We participated in the Interlab Measurement Study. | 4. We participated in the Interlab Measurement Study. | ||
<br><br><br> | <br><br><br> |
Revision as of 02:38, 1 November 2017